Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes generic prescription pharmaceutical products

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products.

Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations.

It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.
Managers
NameAgeSinceTitle
Arthur P. Bedrosian712000Chief Executive Officer & Director
Jeffrey Farber572003Chairman
Martin P. Galvan, CPA652011CFO, Treasurer & Vice President-Finance
Robert Ehlinger602006Chief Information Officer & VP-logistics
Kristin A. Arnold, PhD-2017Vice President-Research & Development
David A. Drabik492010Lead Independent Director
Paul Taveira572012Independent Director
James M. Maher642013Independent Director
Albert R. Paonessa III572015Independent Director
Kevin R. Smith572002Senior Vice President-Sales & Marketing
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 37,794,694 27,237,315 72.1% 605,202 1.6% 72.1%
Shareholders
NameEquities%
Telemus Capital LLC 6,110,620 16.4%
Jeffrey Farber 4,643,874 12.5%
David Farber 3,779,904 10.2%
BlackRock Fund Advisors 3,414,718 9.18%
The Vanguard Group, Inc. 2,609,670 7.02%
Snow Capital Management LP 2,525,635 6.79%
Invesco PowerShares Capital Management LLC 1,898,649 5.11%
Deerfield Management Company LP 1,853,896 4.99%
LSV Asset Management 1,489,057 4.00%
SSgA Funds Management, Inc. 1,186,674 3.19%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.967
JOHNSON & JOHNSON7.17%334 714
ROCHE HOLDING LTD.11.91%225 722
NOVARTIS AG3.31%202 360
PFIZER INC.4.43%201 998
MERCK & CO., INC.5.88%170 880
SANOFI12.63%121 897
BAYER AG14.60%107 831
GLAXOSMITHKLINE PLC-0.77%98 661
BRISTOL-MYERS SQUIBB C..-4.09%92 339
ELI LILLY AND CO11.57%90 541
ALLERGAN PLC16.12%81 814
NOVO NORDISK A/S0.67%76 508
ASTRAZENECA PLC4.51%75 727
ABBOTT LABORATORIES13.62%75 410
SHIRE PLC-3.14%53 094
TAKEDA PHARMACEUTICAL ..10.49%37 859
TEVA PHARMACEUTICAL IN..-17.43%31 951
ASTELLAS PHARMA INC-9.72%28 346
MYLAN NV-2.10%20 001
CHUGAI PHARMACEUTICAL ..17.73%19 819
Sector Pharmaceuticals - NEC
Lannett Company, Inc. : Connections
The American Institute of Certified Public Accountants
National Response Corp.
Kremers Urban Pharmaceuticals, Inc.
Auburn Pharmaceuticals, Inc.
Cranbrook & Co. Llc
Grason-Stadler, Inc.
Generic Pharmaceutical Co.
Company contact information
Lannett Co., Inc.
13200 Townsend Road
Philadelphia, PA 19154

Phone : +1.215.333.9000
Fax : +1.215.333.9004
Web : www.lannett.com
© 2017 People , Fundamentals and Ownership